1. A. A limited-service pharmacy permittee shall ensure that the limited-service long-term care pharmacy complies with:

   1. 1. The general requirements of R4-23-671;
   2. 2. The professional practice standards of Article 4 and Article 11; and
   3. 3. The permits and drug distribution standards of R4-23-606 through R4-23-612, R4-23-670, and this Section.
2. B. If a limited-service long-term care pharmacy permittee contracts with a long-term care facility as a Provider Pharmacy, as defined in R4-23-110, the limited-service long-term care pharmacy permittee shall ensure that the long-term care consultant pharmacist and the pharmacist-in-charge of the limited-service long-term care pharmacy comply with R4-23-701, R4-23-701.01, R4-23-701.02, R4-23-701.03, R4-23-701.04, and this Section.
3. C. The limited-service long-term care pharmacy permittee or pharmacist-in-charge shall ensure that prescription medication is delivered to the patient’s long-term care facility or locked in the dispensing area of the pharmacy when a pharmacist is not present in the pharmacy.
4. D. The pharmacist-in-charge of a limited-service long-term care pharmacy shall authorize only those individuals listed in R4-23-610(B) to be in the limited-service long-term care pharmacy.
5. E. In consultation with the long-term care facility’s medical director and director of nursing, the long-term care consultant pharmacist and pharmacist-in-charge of the long-term care facility’s provider pharmacy may develop, if necessary, a medication formulary for the long-term care facility that ensures the safe and efficient procurement, dispensing, distribution, administration, and control of drugs in the long-term care facility.

6. F. The limited-service long-term care pharmacy permittee or pharmacist-in-charge shall ensure that the written policies and procedures required in R4-23-671(E) include the following:

   1. 1. Clinical services and drug utilization management for:

      1. a. Drug utilization reviews,
      2. b. Inventory audits,
      3. c. Patient outcome monitoring,
      4. d. Drug information, and
      5. e. Education of pharmacy and other health professionals;
   2. 2. Controlled substances;
   3. 3. Drug compounding, dispensing, and storage;

   4. 4. Drug delivery requirements for:

      1. a. Transportation,
      2. b. Security,
      3. c. Temperature and other environmental controls, and
      4. d. Emergency provisions;
   5. 5. Drug product procurement;
   6. 6. Duties and qualifications of professional and support staff;
   7. 7. Emergency drug supply unit procedures;
   8. 8. Formulary, including development, review, modification, use, and documentation, if applicable;
   9. 9. Patient profiles;
   10. 10. Patient education;

   11. 11. Prescription orders, including:

       1. a. Approved abbreviations,
       2. b. Stop-order procedures, and
       3. c. Leave-of-absence and discharge prescription order procedures;

   12. 12. Quality management procedures for:

       1. a. Adverse drug reactions,
       2. b. Drug recalls,
       3. c. Expired and beyond-use-date drugs,
       4. d. Medication or dispensing errors, and
       5. e. Education of professional and support staff;
   13. 13. Recordkeeping;
   14. 14. Sanitation; and
   15. 15. Security.

Historical Note

New Section made by final rulemaking at 9 A.A.R. 1064, effective May 4, 2003 (Supp. 03-1). Amended by final rulemaking at 10 A.A.R. 1192, effective May 1, 2004 (Supp. 04-1). Amended by final rulemaking at 19 A.A.R. 2894, effective November 10, 2013 (Supp. 13-3).